Biogen (BIIB) Tops Q3 EPS by 66c, Updates FY Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $192.16 -1.53%
Revenue Growth %: -5.7%
Financial Fact:
Other: 98.6M
Today's EPS Names:
CPSS, HARL, MCET, More
Revenue Growth %: -5.7%
Financial Fact:
Other: 98.6M
Today's EPS Names:
CPSS, HARL, MCET, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $4.77, $0.66 better than the analyst estimate of $4.11. Revenue for the quarter came in at $2.78 million versus the consensus estimate of $2.67 million.
GUIDANCE:
Biogen sees FY2021 EPS of $18.85-$19.35, versus the consensus of $18.61. Biogen sees FY2021 revenue of $10.8-10.9 billion, versus the consensus of $10.76 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alcoa (AA) Misses Q1 EPS by 19c
- Triumph Financial, Inc. (TFIN) Misses Q1 EPS by 20c
- Equifax (EFX) shares tumble as Q2, full-year guidance falls short
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
